[Real-world evidence : Benefits and limitations in multiple sclerosis research].

about

[Real-world evidence : Benefits and limitations in multiple sclerosis research].

Item

http://www.wikidata.org/entity/Q54304253

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

[Real-world evidence : Benefits and limitations in multiple sclerosis research].

@en

[Real-world evidence : Benefits and limitations in multiple sclerosis research].

@nl

type

Item

label

[Real-world evidence : Benefits and limitations in multiple sclerosis research].

@en

[Real-world evidence : Benefits and limitations in multiple sclerosis research].

@nl

prefLabel

[Real-world evidence : Benefits and limitations in multiple sclerosis research].

@en

[Real-world evidence : Benefits and limitations in multiple sclerosis research].

@nl

P1476

[Real-world evidence : Benefits and limitations in multiple sclerosis research].

@en

P2093

J Kuhle

http://www.w3.org/2001/XMLSchema#string

T Berger

http://www.w3.org/2001/XMLSchema#string

P2860

Optimizing treatment success in multiple sclerosis

Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis.

Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL.

Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding

Using EHRs to integrate research with patient care: promises and challenges.

Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies.

Modeling disease severity in multiple sclerosis using electronic health records

Automated extraction of clinical traits of multiple sclerosis in electronic medical records.

P2888

s00115-017-0387-y

P304

1153-1158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00115-017-0387-Y

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dietrich Rothenbacher

Tjalf Ziemssen

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28776214

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis